{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:20:03Z","timestamp":1791688803851,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Optic neuritis is often an initial symptom in multiple sclerosis (MS) or clinically isolated syndrome (CIS), yet comprehensive studies using the 2017 McDonald criteria for MS are scarce. Patient records from our academic centre (2010\u20132018) were reviewed. Using the 2017 McDonald criteria, three groups were formed: MS optic neuritis (optic neuritis with confirmed MS), CIS optic neuritis (optic neuritis without confirmed MS) and suspected optic neuritis (sON). We compared clinical and paraclinical findings among the groups to identify predictors for CIS- or MS-optic neuritis. The study included 129 MS, 108 CIS, and 44 sON cases. The combination of visual impairment, dyschromatopsia, and retrobulbar pain was observed in 47% of MS patients, 42% of CIS patients, and 30% of sON patients. Dyschromatopsia was the strongest indicator of MS or CIS diagnosis in the backward regression model. 56% of MS patients had relative afferent pupillary defect, 61% optic nerve anomalies within magnetic resonance imaging, and 81% abnormal visual evoked potentials. Our results emphasize the challenges in diagnosing optic neuritis, as not all patients with objectively diagnosed MS exhibit the triad of typical symptoms. To address potentially missing clinical features, incorporating additional paraclinical findings is proposed.<\/jats:p>","DOI":"10.1038\/s41598-024-57199-4","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:01:54Z","timestamp":1711548114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017"],"prefix":"10.1038","volume":"14","author":[{"given":"Konstantin F.","family":"Jendretzky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bajor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa-Marie","family":"Lezius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"H\u00fcmmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Felix","family":"Konen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit M.","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schwenkenbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt-Wolfram","family":"S\u00fchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Trebst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Framme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike P.","family":"Wattjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gingele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"57199_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy, A. T., Mason, D. F. & Miller, D. H. Optic neuritis. Lancet Neurol. 13, 83\u201399 (2014).","journal-title":"Lancet Neurol."},{"key":"57199_CR2","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","volume":"109","author":"Optic Neuritis Study Group","year":"1991","unstructured":"Optic Neuritis Study Group. The clinical profile of optic neuritis: Experience of the optic neuritis treatment trial. Arch. Ophthalmol. 109, 1673\u20131678 (1991).","journal-title":"Arch. Ophthalmol."},{"key":"57199_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1874364101206010065","volume":"6","author":"H Hoorbakht","year":"2012","unstructured":"Hoorbakht, H. Optic neuritis, its differential diagnosis and management. Open Ophthalmol. J. 6, 65\u201372 (2012).","journal-title":"Open Ophthalmol. J."},{"key":"57199_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1756285611398702","volume":"4","author":"E Voss","year":"2011","unstructured":"Voss, E., Raab, P., Trebst, C. & Stangel, M. Clinical approach to optic neuritis: Pitfalls, red flags and differential diagnosis. Ther. Adv. Neurol. Disord. 4, 123\u2013134 (2011).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"57199_CR5","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.msard.2023.104764","volume":"76","author":"R Deschamps","year":"2023","unstructured":"Deschamps, R. et al. Acute optic neuritis: What are the clues to the aetiological diagnosis in real life?. Mult. Scler. Relat. Disord. 76, 1047 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"57199_CR6","doi-asserted-by":"publisher","first-page":"104739","DOI":"10.1016\/j.msard.2023.104739","volume":"75","author":"C-W Lin","year":"2023","unstructured":"Lin, C.-W., Chen, W.-T., Lin, Y.-H., Hung, K. & Chen, T.-C. Clinical characteristics and prognosis of optic neuritis in Taiwan\u2014a hospital-based cohort study. Mult. Scler. Relat. Disord. 75, 104739 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"57199_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"57199_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0084-392X(09)79112-9","volume":"2009","author":"RC Sergott","year":"2009","unstructured":"Sergott, R. C. Multiple sclerosis risk after optic neuritis: Final optic neuritis treatment trial follow-up. Yearb. Ophthalmol. 2009, 187\u2013188 (2009).","journal-title":"Yearb. Ophthalmol."},{"key":"57199_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee, W. J., Hardy, T. A., Fazekas, F. & Miller, D. H. Diagnosis of multiple sclerosis: Progress and challenges. The Lancet 389, 1336\u20131346 (2017).","journal-title":"The Lancet"},{"key":"57199_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121\u2013127 (2001).","journal-title":"Ann. Neurol."},{"key":"57199_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann. Neurol. 58, 840\u2013846 (2005).","journal-title":"Ann. Neurol."},{"key":"57199_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann. Neurol. 69, 292\u2013302 (2011).","journal-title":"Ann. Neurol."},{"key":"57199_CR13","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","volume":"21","author":"A Petzold","year":"2022","unstructured":"Petzold, A. et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 21, 1120\u20131134 (2022).","journal-title":"Lancet Neurol."},{"key":"57199_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","volume":"87","author":"AJ Solomon","year":"2016","unstructured":"Solomon, A. J. et al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology 87, 1393\u20131399 (2016).","journal-title":"Neurology"},{"key":"57199_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrneurol.2017.106","volume":"13","author":"AJ Solomon","year":"2017","unstructured":"Solomon, A. J. & Corboy, J. R. The tension between early diagnosis and misdiagnosis of multiple sclerosis. Nat. Rev. Neurol. 13, 567\u2013572 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"57199_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","volume-title":"International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders (Springer, 2015)."},{"key":"57199_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius, S. et al. MOG encephalomyelitis: International recommendations on diagnosis and antibody testing. J. Neuroinflamm. 15, 134 (2018).","journal-title":"J. Neuroinflamm."},{"key":"57199_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/ijms17091592","volume":"17","author":"P Schwenkenbecher","year":"2016","unstructured":"Schwenkenbecher, P. et al. McDonald criteria 2010 and 2005 compared: Persistence of high oligoclonal band prevalence despite almost doubled diagnostic sensitivity. Int. J. Mol. Sci. 17, 1592 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"57199_CR19","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms18102061","volume":"18","author":"P Schwenkenbecher","year":"2017","unstructured":"Schwenkenbecher, P. et al. Clinically isolated syndrome according to McDonald 2010: Intrathecal IgG synthesis still predictive for conversion to multiple sclerosis. Int. J. Mol. Sci. 18, 2061 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"57199_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1474-4422(23)00112-6","volume":"22","author":"S Gingele","year":"2023","unstructured":"Gingele, S., Jendretzky, K. F., Bajor, A., Meuth, S. G. & Skripuletz, T. Application of diagnostic criteria for optic neuritis. Lancet Neurol. 22, 375\u2013376 (2023).","journal-title":"Lancet Neurol."},{"key":"57199_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange, C., Feltgen, N., Junker, B., Schulze-Bonsel, K. & Bach, M. Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT). Graefes Arch. Clin. Exp. Ophthalmol. 247, 137\u2013142 (2009).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"57199_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12883-016-0657-5","volume":"16","author":"P Schwenkenbecher","year":"2016","unstructured":"Schwenkenbecher, P. et al. Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis. BMC Neurol. 16, 136 (2016).","journal-title":"BMC Neurol."},{"key":"57199_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters, P. et al. Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 87, 1005\u20131015 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"57199_CR24","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl, M. et al. International multicenter examination of MOG antibody assays. Neurol. Neuroimmunol. Neuroinflamm. 7, e674 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"57199_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fneur.2019.00735","volume":"10","author":"S Gingele","year":"2019","unstructured":"Gingele, S. et al. Routine cerebrospinal fluid cytology reveals unique inclusions in macrophages during treatment with nusinersen. Front. Neurol. 10, 735 (2019).","journal-title":"Front. Neurol."},{"key":"57199_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/135245859800400302","volume":"1998","author":"H Reiber","year":"1998","unstructured":"Reiber, H. Cerebrospinal fluid\u2013physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult. Scler. J. 1998, 99\u2013107. https:\/\/doi.org\/10.1177\/135245859800400302 (1998).","journal-title":"Mult. Scler. J."},{"key":"57199_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"M Andersson","year":"1994","unstructured":"Andersson, M. et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report. J. Neurol. Neurosurg. Psychiatry 57, 897\u2013902 (1994).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"57199_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/clinchem\/41.2.256","volume":"41","author":"H Reiber","year":"1995","unstructured":"Reiber, H. External quality assessment in clinical neurochemistry: Survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF\/serum quotients. Clin. Chem. 41, 256\u2013263 (1995).","journal-title":"Clin. Chem."},{"key":"57199_CR29","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/brain\/awz144","volume":"142","author":"M Filippi","year":"2019","unstructured":"Filippi, M. et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines. Brain 142, 1858\u20131875 (2019).","journal-title":"Brain"},{"key":"57199_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1191\/135248506ms1244oa","volume":"12","author":"BA Kallmann","year":"2006","unstructured":"Kallmann, B. A., Fackelmann, S., Toyka, K. V., Rieckmann, P. & Reiners, K. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult. Scler. J. 12, 58\u201365 (2006).","journal-title":"Mult. Scler. J."},{"key":"57199_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12883-016-0608-1","volume":"16","author":"X Giffroy","year":"2016","unstructured":"Giffroy, X. et al. Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis. BMC Neurol. 16, 83 (2016).","journal-title":"BMC Neurol."},{"key":"57199_CR32","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/12764.6181","author":"R Sharma","year":"2015","unstructured":"Sharma, R. Visual evoked potentials: Normative values and gender differences. J. Clin. Diagn. Res. https:\/\/doi.org\/10.7860\/JCDR\/2015\/12764.6181 (2015).","journal-title":"J. Clin. Diagn. Res."},{"key":"57199_CR33","doi-asserted-by":"publisher","first-page":"578130","DOI":"10.1016\/j.jneuroim.2023.578130","volume":"381","author":"S Sarin","year":"2023","unstructured":"Sarin, S. et al. Predicting the final clinical phenotype after the first attack of optic neuritis. J. Neuroimmunol. 381, 578130 (2023).","journal-title":"J. Neuroimmunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57199-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57199-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57199-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:10:09Z","timestamp":1711548609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57199-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57199"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57199-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7293"}}